Simulating workload reduction with an AI-based prostate cancer detection pathway using a prediction uncertainty metric.

Abstract

This study compared two uncertainty quantification (UQ) metrics to rule out prostate MRI scans with a high-confidence artificial intelligence (AI) prediction and investigated the resulting potential radiologist's workload reduction in a clinically significant prostate cancer (csPCa) detection pathway. This retrospective study utilized 1612 MRI scans from three institutes for csPCa (Gleason Grade Group ≥ 2) assessment. We compared the standard diagnostic pathway (radiologist reading) to an AI-based rule-out pathway in terms of efficacy and accuracy in diagnosing csPCa. In the rule-out pathway, 15 AI submodels (trained on 7756 cases) diagnosed each MRI scan, and any prediction deemed uncertain was referred to a radiologist for reading. We compared the mean (meanUQ) and variability (varUQ) of predictions using the DeLong test on the area under the receiver operating characteristic curves (AUROC). The level of workload reduction of the best UQ method was determined based on a maintained sensitivity at non-inferior specificity using the margins 0.05 and 0.10. The workload reduction of the proposed pathway was institute-specific: up to 20% at a 0.10 non-inferiority margin (p < 0.05) and non-significant workload reduction at a 0.05 margin. VarUQ-based rule out gave higher but non-significant AUROC scores than meanUQ in certain selected cases (+0.05 AUROC, p > 0.05). MeanUQ and varUQ showed promise in AI-based rule-out csPCa detection. Using varUQ in an AI-based csPCa detection pathway could reduce the number of scans radiologists need to read. The varying performance of the UQ rule-out indicates the need for institute-specific UQ thresholds. Question AI can autonomously assess prostate MRI scans with high certainty at a non-inferior performance compared to radiologists, potentially reducing the workload of radiologists. Findings The optimal ratio of AI-model and radiologist readings is institute-dependent and requires calibration. Clinical relevance Semi-autonomous AI-based prostate cancer detection with variational UQ scores shows promise in reducing the number of scans radiologists need to read.